CD34(-) cells at the apex of the human hematopoietic stem cell hierarchy have distinctive cellular and molecular signatures.

[1]  Raphael Kopan,et al.  Real-Time Imaging of Notch Activation with a Luciferase Complementation-Based Reporter , 2011, Science Signaling.

[2]  Igor Jurisica,et al.  Isolation of Single Human Hematopoietic Stem Cells Capable of Long-Term Multilineage Engraftment , 2011, Science.

[3]  H. Nakauchi,et al.  Heterogeneity and hierarchy within the most primitive hematopoietic stem cell compartment , 2010, The Journal of experimental medicine.

[4]  Ryan Brinkman,et al.  Long-term propagation of distinct hematopoietic differentiation programs in vivo. , 2007, Cell stem cell.

[5]  B. Porse,et al.  Activation of the canonical Wnt pathway leads to loss of hematopoietic stem cell repopulation and multilineage differentiation block , 2006, Nature Immunology.

[6]  I. Bernstein,et al.  Dose-dependent effects of the Notch ligand Delta1 on ex vivo differentiation and in vivo marrow repopulating ability of cord blood cells. , 2005, Blood.

[7]  K. Jones,et al.  Mastermind recruits CycC:CDK8 to phosphorylate the Notch ICD and coordinate activation with turnover. , 2004, Molecular cell.

[8]  W. Vainchenker,et al.  Membrane-bound Delta-4 Notch ligand reduces the proliferative activity of primitive human hematopoietic CD34+CD38low cells while maintaining their LTC-IC potential , 2004, Leukemia.

[9]  S. Ferrari,et al.  Functional and kinetic characterization of granulocyte colony‐stimulating factor‐primed CD34− human stem cells , 2003, British journal of haematology.

[10]  S. Ikehara,et al.  SCID-repopulating cell activity of human cord blood-derived CD34- cells assured by intra-bone marrow injection. , 2003, Blood.

[11]  K. Ando,et al.  A highly sensitive strategy for SCID-repopulating cell assay by direct injection of primitive human hematopoietic cells into NOD/SCID mice bone marrow. , 2003, Blood.

[12]  G. Seitz,et al.  Identification of a novel class of human adherent CD34- stem cells that give rise to SCID-repopulating cells. , 2003, Blood.

[13]  M. Simon,et al.  C1qRp defines a new human stem cell population with hematopoietic and hepatic potential , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Karine Hovanes,et al.  β-catenin–sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer , 2001, Nature Genetics.

[15]  R. Mulligan,et al.  Hoechst dye efflux reveals a novel CD7(+)CD34(-) lymphoid progenitor in human umbilical cord blood. , 2000, Blood.

[16]  K. Ando,et al.  Ex vivo generation of CD34(+) cells from CD34(-) hematopoietic cells. , 1999, Blood.

[17]  J. Dick,et al.  A newly discovered class of human hematopoietic cells with SCID-repopulating activity , 1998, Nature Medicine.

[18]  M. Ogawa,et al.  Human bone marrow CD34- cells engraft in vivo and undergo multilineage expression that includes giving rise to CD34+ cells. , 1998, Experimental hematology.

[19]  R. Johnson,et al.  Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species , 1997, Nature Medicine.

[20]  F. Rosenbauer,et al.  Hematopoietic stem cell and multilineage defects generated by constitutive beta-catenin activation. , 2006, Nature immunology.

[21]  J. Nolta,et al.  Reversibility of CD34 expression on human hematopoietic stem cells that retain the capacity for secondary reconstitution. , 2003, Blood.

[22]  Transforming growth factor (cid:1) -induced cell cycle arrest of human hematopoietic cells requires p57KIP2 up-regulation , 2022 .